The status has been given to the B7-H3-targeted drug as a treatment for late-line relapsed or refractory osteosarcoma ... or refractory extensive-stage small-cell lung cancer (SCLC), with the ...
A new review was published in Oncotarget, Volume 16, on February 12, 2025, titled “SETDB1 amplification in osteosarcomas: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback